Free Trial

Cynosure Group LLC Purchases 32,007 Shares of Transcat, Inc. (NASDAQ:TRNS)

Transcat logo with Computer and Technology background

Key Points

  • Cynosure Group LLC significantly increased its stake in Transcat, Inc. by 583.4%, acquiring an additional 32,007 shares during the first quarter, bringing its total to 37,493 shares valued at approximately $2.79 million.
  • Several large investors have also boosted their holdings in Transcat, with notable increases from Aquatic Capital Management by 1,052.0% and GAMMA Investing by 10,137.5%.
  • Analysts have a mixed outlook on Transcat, with three maintaining a "buy" rating and three rating it "hold", while the average target price stands at $112.20.
  • Need better tools to track Transcat? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Cynosure Group LLC raised its holdings in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 583.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 37,493 shares of the scientific and technical instruments company's stock after acquiring an additional 32,007 shares during the quarter. Cynosure Group LLC owned 0.40% of Transcat worth $2,791,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Transcat by 3.9% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,137 shares of the scientific and technical instruments company's stock valued at $543,000 after buying an additional 194 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Transcat by 10,137.5% in the 1st quarter. GAMMA Investing LLC now owns 1,638 shares of the scientific and technical instruments company's stock valued at $122,000 after purchasing an additional 1,622 shares during the period. Deutsche Bank AG increased its holdings in shares of Transcat by 49.9% in the 4th quarter. Deutsche Bank AG now owns 7,833 shares of the scientific and technical instruments company's stock valued at $828,000 after purchasing an additional 2,608 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Transcat by 24.1% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 17,029 shares of the scientific and technical instruments company's stock valued at $1,801,000 after purchasing an additional 3,307 shares during the period. Finally, Premier Fund Managers Ltd increased its holdings in shares of Transcat by 52.2% in the 1st quarter. Premier Fund Managers Ltd now owns 6,908 shares of the scientific and technical instruments company's stock valued at $507,000 after purchasing an additional 2,368 shares during the period. 98.34% of the stock is owned by institutional investors and hedge funds.

Transcat Stock Up 2.5%

Transcat stock traded up $2.07 during midday trading on Wednesday, reaching $85.11. The stock had a trading volume of 34,596 shares, compared to its average volume of 106,852. The stock has a market capitalization of $793.23 million, a P/E ratio of 59.52 and a beta of 0.71. Transcat, Inc. has a 1-year low of $67.56 and a 1-year high of $133.72. The firm's fifty day simple moving average is $81.73 and its 200-day simple moving average is $80.48. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.36 and a current ratio of 2.92.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The scientific and technical instruments company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.19. The firm had revenue of $76.42 million for the quarter, compared to analyst estimates of $72.28 million. Transcat had a return on equity of 6.66% and a net margin of 4.64%. As a group, analysts expect that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Lake Street Capital assumed coverage on Transcat in a report on Thursday, July 10th. They issued a "buy" rating and a $105.00 target price on the stock. HC Wainwright restated a "buy" rating and issued a $116.00 price objective on shares of Transcat in a report on Wednesday, June 25th. Finally, Wall Street Zen upgraded Transcat from a "sell" rating to a "hold" rating in a report on Wednesday, May 28th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $112.20.

View Our Latest Research Report on Transcat

Transcat Profile

(Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Read More

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Should You Invest $1,000 in Transcat Right Now?

Before you consider Transcat, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.

While Transcat currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom
3 Growth Stock Winners to Watch And 3 to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines